Avantor (NYSE:AVTR) Announces Quarterly Earnings Results

Avantor (NYSE:AVTR) announced its earnings results on Friday. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.02, Briefing.com reports. The business had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.68 billion. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The business’s revenue for the quarter was down 5.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.29 EPS.

Avantor Price Performance

Shares of Avantor stock traded down $1.21 on Friday, hitting $23.94. The company’s stock had a trading volume of 14,185,165 shares, compared to its average volume of 4,145,237. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.05 and a current ratio of 1.61. Avantor has a 1 year low of $16.63 and a 1 year high of $26.16. The company has a market capitalization of $16.24 billion, a price-to-earnings ratio of 49.88, a price-to-earnings-growth ratio of 2.56 and a beta of 1.37. The firm has a fifty day moving average price of $25.08 and a 200-day moving average price of $22.61.

Insider Buying and Selling

In other news, EVP James Bramwell sold 6,203 shares of the business’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the transaction, the executive vice president now directly owns 101,143 shares in the company, valued at approximately $2,476,992.07. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.50% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. UBS Group increased their target price on Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research report on Thursday, February 15th. Barclays increased their target price on Avantor from $27.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, April 10th. Citigroup raised their price objective on Avantor from $24.00 to $30.00 and gave the stock a “buy” rating in a research report on Thursday, February 15th. Royal Bank of Canada raised their price objective on Avantor from $28.00 to $29.00 and gave the stock an “outperform” rating in a research report on Thursday, February 15th. Finally, Evercore ISI raised their price objective on Avantor from $26.00 to $28.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, Avantor has a consensus rating of “Moderate Buy” and an average price target of $26.71.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.